Literature DB >> 31385070

Sarcoma with MGA-NUTM1 fusion in the lung: an emerging entity.

Taichiro Goto1, Yasuhito Arai2, Tatsuhiro Shibata2, Toshio Oyama3, Akihiko Yoshida4,5.   

Abstract

We here document a sarcoma with a recently reported MGA-NUTM1 fusion. A 49-year-old man presented with a nodule in the right lung, which grew to a giant mass in 5 years. The tumor showed uniform oval to spindle cell proliferation in a hypervascular stroma, associated with focal myxoid change and peculiar collagen deposition resembling an osteoid. The tumor showed an undifferentiated phenotype, including negativity for cytokeratin, although it was immunoreactive to BCOR and MUC4, and was initially suspected as BCOR-associated sarcoma. After complete resection, the tumor recurred in the mediastinal lymph node, and the patient died of the disease. RNA sequencing detected MGA (exon 22)-NUTM1 (exon 3), which was confirmed by reverse transcriptase-polymerase chain reaction, Sanger sequencing, fluorescence in situ hybridization, and NUT immunohistochemistry. Clinicopathological features of the present case were similar to some of the reported cases of MGA-NUTM1 sarcomas, suggesting the emergence of a distinct tumor subtype.

Entities:  

Keywords:  Gene fusion; Lung; MGA; NUTM1; Sarcoma

Year:  2019        PMID: 31385070     DOI: 10.1007/s00428-019-02623-8

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  3 in total

Review 1.  Update on genetically defined lung neoplasms: NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumors.

Authors:  Kyriakos Chatzopoulos; Jennifer M Boland
Journal:  Virchows Arch       Date:  2021-01-06       Impact factor: 4.064

Review 2.  Unusual lung tumors-from morphology to genetics.

Authors:  Jennifer M Boland
Journal:  Mod Pathol       Date:  2021-09-13       Impact factor: 7.842

3.  MUC4 is expressed in alveolar rhabdomyosarcoma.

Authors:  Erna Forgó; Jason L Hornick; Gregory W Charville
Journal:  Histopathology       Date:  2021-03-16       Impact factor: 5.087

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.